FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/26/2024
Back to search
Official data from USPTO
PURMX THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PURMX THERAPEUTICS
ST13
US500000079349366Class
5, 42
Filing
79349366
Registration
7232658
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/26/2024
Trademark type
Word
Nice classes
5, 42
Filing date
07/28/2022
Registration date
12/05/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/05/2023
Last transaction
12/05/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
CHANG, BETTY
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PURMX Therapeutics, Inc.
Representatives
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer
Class 42
Testinginspection and research services in the fields of pharmaceuticalscosmetics and foodstuffs; scientific research; research and development of new products for others
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/06/2024
FIMP
FINAL DISPOSITION PROCESSED
03/06/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/05/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/19/2023
PUBO
PUBLISHED FOR OPPOSITION
09/19/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/17/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/30/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/30/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/30/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/10/2023
RFNT
REFUSAL PROCESSED BY IB
07/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/20/2023
RFRR
REFUSAL PROCESSED BY MPU
06/20/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/17/2023
CNRT
NON-FINAL ACTION WRITTEN
05/16/2023
DOCK
ASSIGNED TO EXAMINER
05/16/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/20/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/15/2022
Continuous trademark protection
Get notified about every new filing that threatens PURMX THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.